Erratum: Kaempferol attenuates myocardial ischemic injury via inhibition of MAPK signaling pathway in experimental model of myocardial ischemia-reperfusion injury (Oxidative Medicine and Cellular Longevity (2016) 2016 (7580731) DOI: 10.1155/2016/7580731);Kaempferol attenuates myocardial ischemic injury via inhibition of MAPK signaling pathway in experimental model of myocardial ischemia-reperfusion injury

Oxidative Medicine and Cellular Longevity

Volumn 2016, Issue , 2016, Pages

  Suchal, Kapil ^a   Malik, Salma ^a   Gamad, Nanda ^a   Malhotra, Rajiv Kumar ^a   Goyal, Sameer N ^b   Chaudhary, Uma ^c   Bhatia, Jagriti ^a   Ojha, Shreesh ^d   Arya, Dharamvir Singh ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b R C PATEL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH   (India)

^c UNIVERSITY OF DELHI   (India)

^d UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DEATH; IMMUNOLOGY; PROTEINS; RATS;

ANTI-APOPTOTIC EFFECTS; ANTI-APOPTOTIC PROTEIN; ANTI-INFLAMMATORIES; EXPERIMENTAL MODELING; ISCHEMIA REPERFUSION; LEFT ANTERIOR DESCENDING; MORPHOLOGICAL ALTERATION; MYOCARDIAL ISCHEMIA-REPERFUSION INJURIES;

FLAVONOIDS;

CASPASE 3; CATALASE; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; KAEMPFEROL; LACTATE DEHYDROGENASE; MALONALDEHYDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN BAX; PROTEIN BCL 2; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; ANTIOXIDANT; BIOLOGICAL MARKER; KAEMPFEROL DERIVATIVE; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; ENZYME ACTIVITY; ENZYME INHIBITION; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE ISCHEMIA; HEART VENTRICLE FUNCTION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LIPID PEROXIDATION; MALE; MITOCHONDRION SWELLING; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REPERFUSION INJURY; ANIMAL; BLOOD PRESSURE; CARDIAC MUSCLE; DISEASE MODEL; DRUG EFFECTS; ENZYMOLOGY; HEART FUNCTION TEST; INFLAMMATION; METABOLISM; MYOCARDIAL REPERFUSION INJURY; PATHOLOGY; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; SURVIVAL ANALYSIS; ULTRASTRUCTURE; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; BIOMARKERS; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; HEART FUNCTION TESTS; INFLAMMATION; INTERLEUKIN-6; KAEMPFEROLS; LIPID PEROXIDATION; MALE; MAP KINASE SIGNALING SYSTEM; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; RATS, WISTAR; SURVIVAL ANALYSIS; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR FUNCTION;

EID: 84964894091     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2020/4530278     Document Type: Erratum

References (29)

1. C. Li, J. He, Y. Gao, Y. Xing, J. Hou, and J. Tian, "Preventive effect of total flavones of Choerospondias axillaries on ischemia/reperfusion-induced myocardial infarctionrelated MAPK signaling pathway, " Cardiovascular Toxicology, vol. 14, no. 2, pp. 145-152, 2014.
2. R. B. Jennings, "Historical perspective on the pathology of myocardial ischemia/reperfusion injury, " Circulation Research, vol. 113, no. 4, pp. 428-438, 2013.
3. Y. Son, Y.-K. Cheong, N.-H. Kim, H.-T. Chung, D. G. Kang, and H.-O. Pae, "Mitogen-activated protein kinases and reactive oxygen species: how can ROS activate MAPK pathways?" Journal of Signal Transduction, vol. 2011, Article ID 792639, 6 pages, 2011.
4. X. F. Gao, Y. Zhou, D. Y. Wang, K. S. Lew, A. M. Richards, and P. Wang, "Urocortin-2 suppression of p38-MAPK signaling as an additional mechanism for ischemic cardioprotection, " Molecular and Cellular Biochemistry, vol. 398, no. 1-2, pp. 135-146, 2015.
5. D.-Y. Li, L. Tao, H. Liu, T. A. Christopher, B. L. Lopez, and X. L. Ma, "Role of ERK1/2 in the anti-apoptotic and cardioprotective effects of nitric oxide after myocardial ischemia and reperfusion, " Apoptosis, vol. 11, no. 6, pp. 923-930, 2006.
6. K. Shimada, M. Nakamura, E. Ishida, M. Kishi, and N. Konishi, "Roles of p38- and c-jun NH2-terminal kinase-mediated pathways in 2-methoxyestradiol-induced p53 induction and apoptosis, " Carcinogenesis, vol. 24, no. 6, pp. 1067-1075, 2003.
7. J. Yu, L. Wang, M. Akinyi et al., "Danshensu protects isolated heart against ischemia reperfusion injury through activation of Akt/ERK1/2/Nrf2 signaling, " International Journal of Clinical and ExperimentalMedicine, vol. 8, no. 9, pp. 14793-14804, 2015.
8. J. Xiao, G.-B. Sun, B. Sun et al., "Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitro, " Toxicology, vol. 292, no. 1, pp. 53-62, 2012.
9. K. S. Al-Numair, G. Chandramohan, C. Veeramani, and M. A. Alsaif, "Ameliorative effect of kaempferol, a flavonoid, on oxidative stress in streptozotocin-induced diabetic rats, " Redox Report, vol. 20, no. 5, pp. 198-209, 2015.
10. C. Luo, H. Yang, C. Tang et al., "Kaempferol alleviates insulin resistance via hepatic IKK/NF-κB signal in type 2 diabetic rats, " International Immunopharmacology, vol. 28, no. 1, pp. 744-750, 2015.
11. E. Jo, S. J. Park, Y. S. Choi, W. Jeon, and B. Kim, "Kaempferol suppresses transforming growth factor-β1-induced epithelialto- mesenchymal transition and migration of A549 lung cancer cells by inhibiting Akt1-mediated phosphorylation of Smad3 at threonine-179, " Neoplasia, vol. 17, no. 7, pp. 525-537, 2015.
12. E.-J. Yang, G.-S. Kim, M. Jun, and K.-S. Song, "Kaempferol attenuates the glutamate-induced oxidative stress in mousederived hippocampal neuronal HT22 cells, " Food and Function, vol. 5, no. 7, pp. 1395-1402, 2014.
13. K. S. Al-Numair, C. Veeramani, M. A. Alsaif, and G. Chandramohan, "Influence of kaempferol, a flavonoid compound, on membrane-bound ATPases in streptozotocin-induced diabetic rats, " Pharmaceutical Biology, vol. 53, no. 9, pp. 1372-1378, 2015.
14. Z. Guo, Z. Liao, L. Huang, D. Liu, D. Yin, and M. He, "Kaempferol protects cardiomyocytes against anoxia/reoxygenation injury via mitochondrial pathway mediated by SIRT1, " European Journal of Pharmacology, vol. 761, pp. 245-253, 2015.
15. H.-Y. Yoon, E.-G. Lee, H. Lee et al., "Kaempferol inhibits IL-1β-induced proliferation of rheumatoid arthritis synovial fibroblasts and the production of COX-2, PGE2 and MMPs, " International Journal of Molecular Medicine, vol. 32, no. 4, pp. 971-977, 2013.
16. H. Ohkawa, N. Ohishi, and K. Yagi, "Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction, " Analytical Biochemistry, vol. 95, no. 2, pp. 351-358, 1979.
17. M. S. Moron, J. W. Depierre, and B. Mannervik, "Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver, " Biochimica et Biophysica Acta (BBA)-General Subjects, vol. 582, no. 1, pp. 67-78, 1979.
18. S. Marklund and G. Marklund, "Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase, " European Journal of Biochemistry, vol. 47, no. 3, pp. 469-474, 1974.
19. H. Aebi, "Catalase in vitro, "Methods in Enzymology, vol. 105, pp. 121-126, 1984.
20. M. M. Bradford, "A rapid and sensitive method for the quantitation ofmicrogramquantities of protein utilizing the principle of protein-dye binding, " Analytical Biochemistry, vol. 72, no. 1-2, pp. 248-254, 1976.
21. S. Malik, A. K. Sharma, S. Bharti et al., "In vivo cardioprotection by pitavastatin from ischemic-reperfusion injury through suppression of IKK/NF-κB and upregulation of pAkt-e-NOS, " Journal of Cardiovascular Pharmacology, vol. 58, no. 2, pp. 199-206, 2011.
22. D. Yu, M. Li, Y. Tian, J. Liu, and J. Shang, "Luteolin inhibitsROSactivated MAPK pathway in myocardial ischemia/reperfusion injury, " Life Sciences, vol. 122, pp. 15-25, 2015.
23. J. M. Calderon-Montano, E. Burgos-Moron, C. Perez-Guerrero, and M. Lopez-Lazaro, "A review on the dietary flavonoid kaempferol, " Mini-Reviews in Medicinal Chemistry, vol. 11, no. 4, pp. 298-344, 2011.
24. H. Wang, Q. Zhu, P. Ye et al., "Pioglitazone attenuatesmyocardial ischemia-reperfusion injury via up-regulation of ERK and COX-2, " BioScience Trends, vol. 6, no. 6, pp. 325-332, 2012.
25. C. J. Thomas, D. C. H. Ng, N. Patsikatheodorou et al., "Cardioprotection from ischaemia-reperfusion injury by a novel flavonol that reduces activation of p38 MAPK, " European Journal of Pharmacology, vol. 658, no. 2-3, pp. 160-167, 2011.
26. L. Zhou, D. Zhao, H. An, H. Zhang, C. Jiang, and B. Yang, "Melatonin prevents lung injury induced by hepatic ischemiareperfusion through anti-inflammatory and anti-apoptosis effects, " International Immunopharmacology, vol. 29, no. 2, pp. 462-467, 2015.
27. L. Ma, H. Liu, Z. Xie et al., "Ginsenoside Rb3 protects cardiomyocytes against ischemia-reperfusion injury via the inhibition of JNK-mediated NF-κB pathway: a mouse cardiomyocyte model, " PLoS ONE, vol. 9, no. 8, Article ID e103628, 2014.
28. W. Wang, L. Tang, Y. Li, and Y. Wang, "Biochanin A protects against focal cerebral ischemia/reperfusion in rats via inhibition of p38-mediated inflammatory responses, " Journal of the Neurological Sciences, vol. 348, no. 1-2, pp. 121-125, 2015.
29. S. Ramachandran, J. M. Liaw, J. Jia et al., "Ischemia-reperfusion injury in rat steatotic liver is dependent on NFκB P65 activation, " Transplant Immunology, vol. 26, no. 4, pp. 201-206, 2012.